Research
Epitranscriptomics & Cancer Adaptation : A.David

Activities

Our research work focuses on the contribution of post-transcriptional mechanisms on cancer cell adaptation, in particular RNA epigenetic & translational control.

More..

Zotero public

Retour ŕ la liste des Items
Added by mollevi
Group name EquipeCG
Item Type Note
Note

Houede, Nadine
Beuzeboc, Philippe
Gourgou, Sophie
Tosi, Diego
Moise, Laura
Gravis, Gwenaelle
Delva, Remy
Flechon, Aude
Latorzeff, Igor
Ferrero, Jean-Marc
Oudard, Stephane
Tartas, Sophie
Laguerre, Brigitte
Topart, Delphine
Roubaud, Guilhem
Agherbi, Hanane
Rebillard, Xavier
Azria, David
eng
Research Support, Non-U.S. Gov't
England
2015/04/18 06:00
BMC Cancer. 2015 Apr 4;15:222. doi: 10.1186/s12885-015-1257-2.
Date Added 2018/07/20 - 10:05:58
Date Modified 2018/07/20 - 10:05:58
Parent item Abiraterone acetate in patients with metastatic castration-resistant prostate cancer: long term outcome of the Temporary Authorization for Use programme in France


Who are we ?

Located in the Parc Euromédecine, the Institut de Recherche en Cancérologie de Montpellier (U1194) is located on the Val d'Aurelle Campus (ICM, Institut régional du Cancer Montpellier/ Val d'Aurelle).

U1194 Research Centre supported by Inserm, the University of Montpellier and the Institut du Cancer de Montpellier (ICM)

More                                                                                                                 Join us

Contact us

Institut de Recherche en Cancérologie de
Montpellier (U1194) - Campus Val d'Aurelle

208 avenue des Apothicaires
34298 Montpellier cedex 5 FRANCE

 

insermUM1ICM

© Institut de Recherche en Cancérologie de Montpellier - 2011 - Tous droits réservés - Mentions légales - Connexion - Conception : ID Alizés